#ExistRefRangeSet>
Reference Interval:
#ExistRefRangeTable> | Age
| Male
| Female
| | 7-9 years
| 167-578 nM BCE/mM creatinine
| 201-626 nM BCE/mM creatinine
| | 10-12 years
| 152-505 nM BCE/mM creatinine
| 173-728 nM BCE/mM creatinine
| | 13-15 years
| 103-776 nM BCE/mM creatinine
| 38-515 nM BCE/mM creatinine
| | 16-17 years
| 34-313 nM BCE/mM creatinine
| 20-144 nM BCE/mM creatinine
| | 18 years and older
| 21-83 nM BCE/mM creatinine
| | | Premenopausal
| | 17-94 nM BCE/mM creatinine
| | Postmenopausal
| | 26-124 nM BCE/mM creatinine
|
*ExistRefRangeTable>
|
*ExistRefRangeSet>
#ExistInterpDataSet>
| Interpretive Data: |
#ExistInterpData>NTx Units = nM BCE/mM creatinine
A decrease of 30-40% from the NTx baseline after three months of therapy is a typical response to anti-resorptive therapy.
NTx = Cross-linked N-telopeptide of Type I Collagen BCE = Bone Collagen Equivalent
*ExistInterpData>
|
*ExistInterpDataSet>
#ExistCPT>
| CPT Code(s): |
82523
|
*ExistCPT>
#ExistCrossReferences>
Cross References: |
Cross-Linked N-Telopeptide (N-Telopeptide, Cross-Linked, Urine), NTx (N-Telopeptide, Cross-Linked, Urine) |
*ExistCrossReferences>